Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Wet Age Related Macular Degeneration (AMD) Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Bayer AG
  • 5.1.1 Bayer AG Company Profile
  • 5.1.2 Bayer AG Business Overview
  • 5.1.3 Bayer AG Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Bayer AG Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.2 Regeneron Pharmaceuticals Inc.
  • 5.2.1 Regeneron Pharmaceuticals Inc. Company Profile
  • 5.2.2 Regeneron Pharmaceuticals Inc. Business Overview
  • 5.2.3 Regeneron Pharmaceuticals Inc. Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Regeneron Pharmaceuticals Inc. Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.3 Gilead Sciences Inc.
  • 5.3.1 Gilead Sciences Inc. Company Profile
  • 5.3.2 Gilead Sciences Inc. Business Overview
  • 5.3.3 Gilead Sciences Inc. Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Gilead Sciences Inc. Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.4 Ophthotech Corporation
  • 5.4.1 Ophthotech Corporation Company Profile
  • 5.4.2 Ophthotech Corporation Business Overview
  • 5.4.3 Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.5 Neurotech Pharmaceuticals Inc.
  • 5.5.1 Neurotech Pharmaceuticals Inc. Company Profile
  • 5.5.2 Neurotech Pharmaceuticals Inc. Business Overview
  • 5.5.3 Neurotech Pharmaceuticals Inc. Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 Neurotech Pharmaceuticals Inc. Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.6 Novartis AG
  • 5.6.1 Novartis AG Company Profile
  • 5.6.2 Novartis AG Business Overview
  • 5.6.3 Novartis AG Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Novartis AG Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.7 Alimera Sciences Inc.
  • 5.7.1 Alimera Sciences Inc. Company Profile
  • 5.7.2 Alimera Sciences Inc. Business Overview
  • 5.7.3 Alimera Sciences Inc. Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Alimera Sciences Inc. Wet Age Related Macular Degeneration (AMD) Products Introduction
• 5.8 Kubota Pharmaceutical Holdings Co. Ltd.
  • 5.8.1 Kubota Pharmaceutical Holdings Co. Ltd. Company Profile
  • 5.8.2 Kubota Pharmaceutical Holdings Co. Ltd. Business Overview
  • 5.8.3 Kubota Pharmaceutical Holdings Co. Ltd. Wet Age Related Macular Degeneration (AMD) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 Kubota Pharmaceutical Holdings Co. Ltd. Wet Age Related Macular Degeneration (AMD) Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Wet Age Related Macular Degeneration (AMD) Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Wet Age Related Macular Degeneration (AMD) Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Wet Age Related Macular Degeneration (AMD) Price by Types (2015-2020)
• 6.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Types (2020-2025)
  • 6.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Wet Age Related Macular Degeneration (AMD) Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Wet Age Related Macular Degeneration (AMD) Sales, Price and Growth Rate of Lucentis
  • 6.3.2 Global Wet Age Related Macular Degeneration (AMD) Sales, Price and Growth Rate of Eylea
  • 6.3.3 Global Wet Age Related Macular Degeneration (AMD) Sales, Price and Growth Rate of Avastin
  • 6.3.4 Global Wet Age Related Macular Degeneration (AMD) Sales, Price and Growth Rate of Others
• 6.4 Global Wet Age Related Macular Degeneration (AMD) Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Lucentis Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Eylea Market Revenue and Sales Forecast (2020-2025)
  • 6.4.3 Avastin Market Revenue and Sales Forecast (2020-2025)
  • 6.4.4 Others Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Wet Age Related Macular Degeneration (AMD) Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Wet Age Related Macular Degeneration (AMD) Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Wet Age Related Macular Degeneration (AMD) Revenue, Sales and Growth Rate of Above 80 Years (2015-2020)
  • 7.3.2 Global Wet Age Related Macular Degeneration (AMD) Revenue, Sales and Growth Rate of 60–80 Years (2015-2020)
  • 7.3.3 Global Wet Age Related Macular Degeneration (AMD) Revenue, Sales and Growth Rate of 40–59 Years (2015-2020)
• 7.4 Global Wet Age Related Macular Degeneration (AMD) Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Above 80 Years Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 60–80 Years Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 40–59 Years Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Wet Age Related Macular Degeneration (AMD) Sales by Regions (2015-2020)
• 8.2 Global Wet Age Related Macular Degeneration (AMD) Market Revenue by Regions (2015-2020)
• 8.3 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Regions (2020-2025)

9 North America Wet Age Related Macular Degeneration (AMD) Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)
• 9.3 North America Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Wet Age Related Macular Degeneration (AMD) Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Wet Age Related Macular Degeneration (AMD) Market Analysis by Country
  • 9.6.1 U.S. Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 9.6.2 Canada Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 9.6.3 Mexico Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate

10 Europe Wet Age Related Macular Degeneration (AMD) Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Wet Age Related Macular Degeneration (AMD) Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Wet Age Related Macular Degeneration (AMD) Market Analysis by Country
  • 10.6.1 Germany Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 10.6.2 United Kingdom Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 10.6.3 France Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 10.6.4 Italy Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 10.6.5 Spain Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 10.6.6 Russia Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate

11 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Analysis by Country
  • 11.6.1 China Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 11.6.2 Japan Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 11.6.3 South Korea Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 11.6.4 Australia Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 11.6.5 India Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate

12 South America Wet Age Related Macular Degeneration (AMD) Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)
• 12.3 South America Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Wet Age Related Macular Degeneration (AMD) Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Wet Age Related Macular Degeneration (AMD) Market Analysis by Country
  • 12.6.1 Brazil Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 12.6.2 Argentina Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 12.6.3 Columbia Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate

13 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Analysis by Country
  • 13.6.1 UAE Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 13.6.2 Egypt Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate
  • 13.6.3 South Africa Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate 2015-2025

Table Wet Age Related Macular Degeneration (AMD) Key Market Segments

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) Segment by Type from 2015-2020

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Wet Age Related Macular Degeneration (AMD)

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Bayer AG Company Profile

Table Bayer AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bayer AG Production and Growth Rate

Figure Bayer AG Market Revenue ($) Market Share 2015-2020

Table Regeneron Pharmaceuticals Inc. Company Profile

Table Regeneron Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Regeneron Pharmaceuticals Inc. Production and Growth Rate

Figure Regeneron Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020

Table Gilead Sciences Inc. Company Profile

Table Gilead Sciences Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Gilead Sciences Inc. Production and Growth Rate

Figure Gilead Sciences Inc. Market Revenue ($) Market Share 2015-2020

Table Ophthotech Corporation Company Profile

Table Ophthotech Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Ophthotech Corporation Production and Growth Rate

Figure Ophthotech Corporation Market Revenue ($) Market Share 2015-2020

Table Neurotech Pharmaceuticals Inc. Company Profile

Table Neurotech Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Neurotech Pharmaceuticals Inc. Production and Growth Rate

Figure Neurotech Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020

Table Novartis AG Company Profile

Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novartis AG Production and Growth Rate

Figure Novartis AG Market Revenue ($) Market Share 2015-2020

Table Alimera Sciences Inc. Company Profile

Table Alimera Sciences Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Alimera Sciences Inc. Production and Growth Rate

Figure Alimera Sciences Inc. Market Revenue ($) Market Share 2015-2020

Table Kubota Pharmaceutical Holdings Co. Ltd. Company Profile

Table Kubota Pharmaceutical Holdings Co. Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Kubota Pharmaceutical Holdings Co. Ltd. Production and Growth Rate

Figure Kubota Pharmaceutical Holdings Co. Ltd. Market Revenue ($) Market Share 2015-2020

Table Global Wet Age Related Macular Degeneration (AMD) Sales by Types (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Sales Share by Types (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Revenue ($) by Types (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Types (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Price ($) by Types (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales by Types (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales Share by Types (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) by Types (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue Share by Types (2020-2025)

Figure Global Lucentis Sales and Growth Rate (2015-2020)

Figure Global Lucentis Price (2015-2020)

Figure Global Eylea Sales and Growth Rate (2015-2020)

Figure Global Eylea Price (2015-2020)

Figure Global Avastin Sales and Growth Rate (2015-2020)

Figure Global Avastin Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of Lucentis (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of Lucentis (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of Eylea (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of Eylea (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of Avastin (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of Avastin (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of Others (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Sales by Applications (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Sales Share by Applications (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Revenue ($) by Applications (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Applications (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales by Applications (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales Share by Applications (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Above 80 Years Sales and Growth Rate (2015-2020)

Figure Global Above 80 Years Price (2015-2020)

Figure Global 60–80 Years Sales and Growth Rate (2015-2020)

Figure Global 60–80 Years Price (2015-2020)

Figure Global 40–59 Years Sales and Growth Rate (2015-2020)

Figure Global 40–59 Years Price (2015-2020)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of Above 80 Years (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of Above 80 Years (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of 60–80 Years (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of 60–80 Years (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Market Revenue ($) and Growth Rate Forecast of 40–59 Years (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate Forecast of 40–59 Years (2020-2025)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales and Growth Rate (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Sales by Regions (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Sales Market Share by Regions (2015-2020)

Figure Global Wet Age Related Macular Degeneration (AMD) Sales Market Share by Regions in 2019

Figure Global Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Revenue by Regions (2015-2020)

Table Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)

Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions in 2019

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales by Regions (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Sales Share by Regions (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure North America Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)

Figure North America Wet Age Related Macular Degeneration (AMD) Market Forecast Sales (2020-2025)

Figure North America Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Canada Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Mexico Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Europe Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Europe Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)

Figure Europe Wet Age Related Macular Degeneration (AMD) Market Forecast Sales (2020-2025)

Figure Europe Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure France Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Italy Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Spain Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Russia Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Forecast Sales (2020-2025)

Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Japan Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure South Korea Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Australia Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure India Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure South America Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure South America Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)

Figure South America Wet Age Related Macular Degeneration (AMD) Market Forecast Sales (2020-2025)

Figure South America Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) (2020-2025)

Figure Brazil Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Argentina Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Columbia Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Forecast Sales (2020-2025)

Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Forecast Revenue ($) (2020-2025)

Figure UAE Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure Egypt Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Figure South Africa Wet Age Related Macular Degeneration (AMD) Market Sales and Growth Rate (2015-2020)

Based on the Wet Age Related Macular Degeneration (AMD) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Wet Age Related Macular Degeneration (AMD) market covered in Chapter 5:
Bayer AG
Regeneron Pharmaceuticals Inc.
Gilead Sciences Inc.
Ophthotech Corporation
Neurotech Pharmaceuticals Inc.
Novartis AG
Alimera Sciences Inc.
Kubota Pharmaceutical Holdings Co. Ltd.

In Chapter 6, on the basis of types, the Wet Age Related Macular Degeneration (AMD) market from 2015 to 2025 is primarily split into:
Lucentis
Eylea
Avastin
Others

In Chapter 7, on the basis of applications, the Wet Age Related Macular Degeneration (AMD) market from 2015 to 2025 covers:
Above 80 Years
60–80 Years
40–59 Years

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025